FDA moves to ease path for biosimilars as Trump seeks to cut drug costs statnews.comHHS Sec. Robert F. Kennedy & FDA Commissioner Marty Makary on Drug Prices C-SPANFDA to streamline approvals for generic biological drugs in latest move targeting health costs CNNFDA to speed up approvals of generic biologic medicines as Trump targets high drug costs CNBCF.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs The New York Times
